Abstract

A novel in situ synthesis of BaSO4 as an X-ray imaging contrast agent within poly(N-isopropylacrylamide) (PNIPAM) microgels has been accomplished by one-step droplet microfluidics with interlinking reactions. A one-step droplet microfluidics device with wavy channels is employed to produce monodispersed PNIPAM microgels (∼40 μm) via free radical polymerization by the initiation of the ammonium persulfate (APS) and N,N,N′,N′-tetramethylethylenediamine (TEMED) complex. The resulting PNIPAM microgels are subsequently dripped into a collecting bath containing an aqueous BaCl2 solution. For the in situ synthesis of BaSO4, Ba2+ ions would diffuse into the PNIPAM microgels and further react with SO42− ions originated from the decomposed by-product of the APS–TEMED complex during the initiation, yielding almost 100% atom efficiency of persulfate ions. The morphologies and the composition of the PNIPAM microgels containing in situ synthesized BaSO4 (BaSO4–PNIPAM microgels) are characterized by scanning electron microscopy combined with energy-dispersive X-ray spectroscopy (SEM–EDX) and X-ray diffraction (XRD). These results show that 14 nm BaSO4 crystallites have been in situ synthesized in the PNIPAM microgels. The resulting BaSO4–PNIPAM microgels are also visible under X-ray radiation by an in vitro fluoroscopic evaluation. This droplet microfluidics based method provides a green and atom-economical reaction approach to synthesize functionalized microgels with a uniform distribution of BaSO4 nano-crystallites. Moreover, the radiopaque BaSO4–PNIPAM microgels also possess great potential in the fields of endovascular embolization, diagnostic imaging, and visible implantation materials.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.